Last Updated: July 6, 2018
- Fresenius Kabi had thiamine injection on shortage due to short-term manufacturing delays.
- Mylan Institutional did not provide a reason for the shortage.
- Thiamine injection, Fresenius Kabi, 100 mg/mL, 2 mL vial, 25 count, NDC 63323-0013-02
- Thiamine injection, Mylan Institutional, 100 mg/mL, 2 mL vial, 25 count, NDC 67457-0196-02
Estimated Resupply Dates
- All marketed presentations are available.
Updated July 6, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 1, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.